Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis.

导出 OA

翻译打印收藏纠错

作者： Brittany,Weber ^[1] ; Katherine P,Liao ^[2]

作者单位： Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA; Cardiovascular Imaging Program, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: bweber@bwh.harvard.edu. ^[1] Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ^[2]

关键词 Cardiovascular Disease-modifying antirheumatic drug (DMARD)Inflammation Psoriatic arthritis Rheumatoid arthritis Spondylarthritis

主题词人类(Humans);抗风湿药(Antirheumatic Agents);心血管疾病(Cardiovascular Diseases);前瞻性研究(Prospective Studies);关节炎, 类风湿(Arthritis, Rheumatoid);生物制品(Biological Products)

DOI 10.1016/j.rdc.2022.08.005

PMID 36424023

发布时间 2024-02-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交